
FDA Safety Concerns Crush Turning Point Brands Stock 14% on Nicotine Pouch Risks
Turning Point Brands stock drops 14% after FDA scientists express safety concerns about nicotine pouches, threatening approval of key products.
TPBregulatory riskFDA approval